Do you need functional data that can quickly assess the status of a pathogenicity-uncertain variant?
NemaMetrix is a market leader in evaluating how human genes function in model systems such as C. elegans and Zebrafish. Our technology can help you answer enduring questions about whether variants are benign or pathogenic, and why.
Our groundbreaking approach with C. elegans replaces the orthologous gene with the human coding sequence, leading to greater translational relevance and the ability to evaluate all variants, not just those with conserved loci.
You can download a brief white paper describing our novel approach.
If you are interested in learning more, you can email us at email@example.com.